These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87 related articles for article (PubMed ID: 2444553)
1. Proton relaxation times in bleomycin-induced lung injury. Taylor CR; Sostman HD; Gore JC; Smith GW Invest Radiol; 1987 Aug; 22(8):621-6. PubMed ID: 2444553 [TBL] [Abstract][Full Text] [Related]
2. Characterization of bleomycin lung injury by nuclear magnetic resonance: correlation between NMR relaxation times and lung water and collagen content. Cutillo AG; Chan PH; Ailion DC; Watanabe S; Rao NV; Hansen CB; Albertine KH; Laicher G; Durney CH Magn Reson Med; 2002 Feb; 47(2):246-56. PubMed ID: 11810667 [TBL] [Abstract][Full Text] [Related]
3. Modulation of bleomycin-induced pulmonary toxicity in the hamster by the antioxidant amifostine. Nici L; Santos-Moore A; Kuhn C; Calabresi P Cancer; 1998 Nov; 83(9):2008-14. PubMed ID: 9806661 [TBL] [Abstract][Full Text] [Related]
4. Structural and functional correlations in a large animal model of bleomycin-induced pulmonary fibrosis. Organ L; Bacci B; Koumoundouros E; Barcham G; Milne M; Kimpton W; Samuel C; Snibson K BMC Pulm Med; 2015 Jul; 15():81. PubMed ID: 26227819 [TBL] [Abstract][Full Text] [Related]
5. Differentiation of parenchymal lung disorders with in vitro proton nuclear magnetic resonance. Vinitski S; Pearson MG; Karlik SJ; Morgan WK; Carey LS; Perkins G; Goto T; Befus D Magn Reson Med; 1986 Feb; 3(1):120-5. PubMed ID: 2421131 [TBL] [Abstract][Full Text] [Related]
7. FTY720 promotes pulmonary fibrosis when administered during the remodelling phase following a bleomycin-induced lung injury. Gendron DR; Lemay AM; Lecours PB; Perreault-Vallières V; Huppé CA; Bossé Y; Blanchet MR; Dion G; Marsolais D Pulm Pharmacol Ther; 2017 Jun; 44():50-56. PubMed ID: 28323056 [TBL] [Abstract][Full Text] [Related]
8. [Effect of water-soluble C(60) fullerenes on pulmonary fibrosis induced by bleomycin in mice]. Dong R; Liu M; Huang XX; Liu Z; Jiang DY; Xiao HJ; Dai HP Zhonghua Yi Xue Za Zhi; 2017 Jun; 97(22):1740-1744. PubMed ID: 28606286 [No Abstract] [Full Text] [Related]
9. Deferoxamine injection does not affect bleomycin-induced lung fibrosis in rats. Cross CE; Warren D; Gerriets JE; Wilson DW; Halliwell B; Last JA J Lab Clin Med; 1985 Oct; 106(4):433-8. PubMed ID: 2413151 [TBL] [Abstract][Full Text] [Related]
10. Use of human amniotic epithelial cells in mouse models of bleomycin-induced lung fibrosis: A systematic review and meta-analysis. He F; Zhou A; Feng S PLoS One; 2018; 13(5):e0197658. PubMed ID: 29772024 [TBL] [Abstract][Full Text] [Related]
11. Fourteen-membered ring macrolides inhibit vascular cell adhesion molecule 1 messenger RNA induction and leukocyte migration: role in preventing lung injury and fibrosis in bleomycin-challenged mice. Li Y; Azuma A; Takahashi S; Usuki J; Matsuda K; Aoyama A; Kudoh S Chest; 2002 Dec; 122(6):2137-45. PubMed ID: 12475858 [TBL] [Abstract][Full Text] [Related]
13. The transcription factor NRF2 protects against pulmonary fibrosis. Cho HY; Reddy SP; Yamamoto M; Kleeberger SR FASEB J; 2004 Aug; 18(11):1258-60. PubMed ID: 15208274 [TBL] [Abstract][Full Text] [Related]
14. Neutralization of the CXC chemokine, macrophage inflammatory protein-2, attenuates bleomycin-induced pulmonary fibrosis. Keane MP; Belperio JA; Moore TA; Moore BB; Arenberg DA; Smith RE; Burdick MD; Kunkel SL; Strieter RM J Immunol; 1999 May; 162(9):5511-8. PubMed ID: 10228032 [TBL] [Abstract][Full Text] [Related]
15. [The pivotal role of CXCR3 in the pathogenesis of bleomycin-induced pulmonary fibrosis]. Gao JM; Lu B Zhonghua Jie He He Hu Xi Za Zhi; 2005 Jan; 28(1):28-32. PubMed ID: 15774188 [TBL] [Abstract][Full Text] [Related]
16. Exacerbation of bleomycin-induced injury and fibrosis by pneumonectomy in the residual lung of mice. Kakizaki T; Kohno M; Watanabe M; Tajima A; Izumi Y; Miyasho T; Tasaka S; Fukunaga K; Maruyama I; Ishizaka A; Kobayashi K J Surg Res; 2009 Jun; 154(2):336-44. PubMed ID: 19118846 [TBL] [Abstract][Full Text] [Related]
17. In vivo MRI of altered proton signal intensity and T2 relaxation in a bleomycin model of pulmonary inflammation and fibrosis. Jacob RE; Amidan BG; Soelberg J; Minard KR J Magn Reson Imaging; 2010 May; 31(5):1091-9. PubMed ID: 20432343 [TBL] [Abstract][Full Text] [Related]
18. Conditioned medium from amniotic membrane-derived cells prevents lung fibrosis and preserves blood gas exchanges in bleomycin-injured mice-specificity of the effects and insights into possible mechanisms. Cargnoni A; Piccinelli EC; Ressel L; Rossi D; Magatti M; Toschi I; Cesari V; Albertini M; Mazzola S; Parolini O Cytotherapy; 2014 Jan; 16(1):17-32. PubMed ID: 24094500 [TBL] [Abstract][Full Text] [Related]
19. Resistance of fibrogenic responses to glucocorticoid and 2-methoxyestradiol in bleomycin-induced lung fibrosis in mice. Langenbach SY; Wheaton BJ; Fernandes DJ; Jones C; Sutherland TE; Wraith BC; Harris T; Schuliga MJ; McLean C; Stewart AG Can J Physiol Pharmacol; 2007 Jul; 85(7):727-38. PubMed ID: 17823636 [TBL] [Abstract][Full Text] [Related]
20. Role of Eotaxin-1 (CCL11) and CC chemokine receptor 3 (CCR3) in bleomycin-induced lung injury and fibrosis. Huaux F; Gharaee-Kermani M; Liu T; Morel V; McGarry B; Ullenbruch M; Kunkel SL; Wang J; Xing Z; Phan SH Am J Pathol; 2005 Dec; 167(6):1485-96. PubMed ID: 16314464 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]